Skip to content

Study on the clinical effect and mechanism of Mongolian Mind-Body Interactive Therapy for patients with chronic protracted withdrawal syndrome

Study on the clinical effect and mechanism of Mongolian Mind-Body Interactive Therapy for patients with chronic protracted withdrawal syndrome

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2024000662
Enrollment
Unknown
Registered
2024-11-06
Start date
2024-09-05
Completion date
Unknown
Last updated
2024-11-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic protracted withdrawal syndrome

Interventions

Control group:Routine management of drug rehabilitation center
Treatment group:Mongolian medicine mind-body interactive therapy and routine management of drug rehabilitation center

Sponsors

Inner Mongolia Traditional Chinese&Mongolian Medical Research Institute
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: a. Meet the diagnostic criteria for dependence on psychoactive Substances (DSM-5); The types of drugs were heroin and morphine; b. Four negative infections; c. Aged between 18 and 60 years old; d. Primary school education or above; e. Stay away from drug rehabilitation for six months or more; f. No obvious withdrawal symptoms (has left the physiological detoxification period); g. No acute mental disorder severe cognitive impairment or serious physical disease; h. Informed consent volunteer subjects.

Exclusion criteria

Exclusion criteria: i. Severe hepatic and renal dysfunction pulmonary insufficiency or other serious diseases of the system (ALTAST greater than 180IU/L); j. Blood pressure below 85/55mmHg or heart rate below 50 beats/min; k. People with serious infectious diseases; l. People with a history of severe neurological or mental illness; Other serious physical diseases history of HIV infection severe malnutrition. m. Other reasons considered unsuitable for inclusion by researchers.

Design outcomes

Primary

MeasureTime frame
Hamilton anxiety scale;Hamilton depression scale;

Secondary

MeasureTime frame
Athens Insomnia Scale;SF36;Trait coping style questionnaire;Pittsburgh sleep quality index;

Countries

China

Contacts

Public ContactJunFang

Inner Mongolia Traditional Chinese&Mongolian Medical Research Institute

340695804@qq.com18547141486

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026